<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03631797</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A2341-54</org_study_id>
    <nct_id>NCT03631797</nct_id>
  </id_info>
  <brief_title>Preoperative Evaluation of Microcirculation for Prediction of Complications After Cardiac Surgery</brief_title>
  <acronym>MONS</acronym>
  <official_title>L'Etude préopératoire de la Microcirculation Pour la prédiction Des Complications après Une Chirurgie Cardiaque Sous Circulation Extracorporelle.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery is responsible for many complications. Microcirculation is involved in many
      of them. The objective of this study is to prospectively investigate the prognostic value of
      preoperative microcirculatory assessment in patients scheduled for cardiac surgery with CPB
      for the occurrence of postoperative complications.

      Microvascular dysfunction is suspected of being involved in postoperative psycho-cognitive
      decline. The influence of microcirculation on the evolution of psycho-cognitive assessment is
      also analyzed in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients are included during the preoperative assessment. Written consent is signed
      after complete explanation of the protocol.

      Patient characteristics as treatments, medical history, and EuroSCORE II are registered.
      Moreover, intraoperative data is collected. Psycho-cognitive and functional evaluation is
      made preoperatively.

      Microcirculation is evaluated for each patient before surgery. Complications are registered
      at the end of hospital stay. Psycho-cognitive and functional evaluation is repeated by call
      30 days after the surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Anticipated">March 13, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complication</measure>
    <time_frame>30 postoperative days</time_frame>
    <description>Composite criteria and include microcirculation postoperative complications:
Late surgical re-intervention (greater than 12 hours) for evacuation of pericardial effusion (seeps),
Surgical wound disunion or surgical site infection,
Organ failure: SOFA score greater than 2 at 48h,
Postoperative confusion: assessed using the Confusion Assessment Method (CAM) or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU),
Acute renal failure ≥ stage 2 according to the KDIGO classification,
Acute lung injury defined as PaO2 &lt;55mmHg in ambient air, PaO2 / FiO2 ratio &lt;250 or Pulse Oxygen Saturation (SpO2) &lt;90% and need for oxygen therapy,
Atrial fibrillation (excluding patients with permanent Atrial Fibrillation preoperatively),
Hepatocellular injury (Cytolysis &gt; 10N, Prothrombin rate and Factor V decreased &lt; 60%).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of degree of disability</measure>
    <time_frame>Inclusion and 30 days after surgery</time_frame>
    <description>Change of modified Rankin scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional evolution</measure>
    <time_frame>Inclusion and 30 days after surgery</time_frame>
    <description>Change of ADL score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood evolution</measure>
    <time_frame>Inclusion and 30 days after surgery</time_frame>
    <description>Change of brief Geriatric Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive evolution</measure>
    <time_frame>Inclusion and 30 days after surgery</time_frame>
    <description>Change of Mc Nair test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Extracorporeal Circulation; Complications</condition>
  <arm_group>
    <arm_group_label>Microvascular reactivity evaluation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients referred for a preoperative arterial palmar arches assessment before cardiac valvular or coronary surgery.
Intervention is measurement of microvascular reactivity with a laser speckle contrast imaging before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microvascular reactivity evaluation</intervention_name>
    <description>Microcirculation will be evaluated for each patient before surgery with a laser speckle contrast imaging (LSCI) placed on the forearm. Tests will be performed for evaluation of endothelium reactivity: Iontophoresis.</description>
    <arm_group_label>Microvascular reactivity evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Valvular ou coronary elective cardiac surgery under cardiopulmonary bypass

          -  Fair skin phototype

          -  Ability to understand the study goal, no dementia.

          -  Affiliation to the French National Healthcare System

          -  Voluntary patients who have signed an informed consent

        Exclusion Criteria:

          -  Emergency surgery

          -  Multiple procedures, combined surgery (valvular and coronary)

          -  Single aortic surgery

          -  Patient already included in the study (second surgery)

          -  Patients protected by decision of law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samir HENNI, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Angers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stanislas ABRARD, MD</last_name>
    <phone>0(33)683237054</phone>
    <email>stanislas.abrard@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samir HENNI, MD PhD</last_name>
    <phone>0(33)241354617</phone>
    <email>samir.henni@chu-angers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UH Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislas ABRARD, MD</last_name>
      <phone>0(33)683237054</phone>
      <email>stanislas.abrard@chu-angers.fr</email>
    </contact>
    <contact_backup>
      <last_name>Samir HENNI, MD PhD</last_name>
      <phone>0(33)241354617</phone>
      <email>samir.henni@chu-angers.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Samir HENNI, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stanislas ABRARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre ABRAHAM, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe BAUFRETON, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyril SARGENTINI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoit COUSIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Sophie FERNANDEZ-LEGRAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanguy LE MELINER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Sophie GOURDIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe BOUYE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean François HAMEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sigismond LASOCKI, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>March 20, 2019</last_update_submitted>
  <last_update_submitted_qc>March 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thoracic Surgery</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Endothelium, vascular</keyword>
  <keyword>Microvascular reactivity</keyword>
  <keyword>Laser Speckle</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

